Search





Search





Markets
/
Stocks
/
knsa
/

Kiniksa Pharmaceuticals International PLC

KNSA

Add to Watchlist

79.150USD

+15.615+24.58%

Close 07-28 16:00（ET）Quotes delayed by 15 min

6.04BMarket Cap

81.35P/E TTM

Kiniksa Pharmaceuticals International PLC

79.150

+15.615+24.58%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

KNSA Cash Flow Statement

You can access the annual and quarterly cash flow statements of Kiniksa Pharmaceuticals International PLC to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

68.01%47.20M

124.87%50.20M

187.13%53.89M

1606.13%33.68M

443.54%28.09M

459.92%22.32M

333.99%18.77M

-113.16%-2.24M

238.07%5.17M

193.44%3.99M

137.36%4.33M

-72.63%16.99M

52.16%-3.74M

88.42%-4.27M

38.70%-11.58M

317.66%62.05M

79.83%-7.82M

8.17%-36.85M

54.16%-18.88M

16.93%-28.51M

-32.71%-38.78M

-26.19%-40.12M

-70.42%-41.19M

-17.27%-34.32M

29.88%-29.22M

49.73%-31.80M

12.55%-24.17M

-42.87%-29.27M

-132.61%-41.68M

-322.50%-63.26M

-18.22%-27.64M

-87.20%-20.48M

-75.35%-17.92M

-163.64%-14.97M

---23.38M

---10.94M

---10.22M

---5.68M

Net income from continuing operations

42.62%25.43M

164.57%22.59M

259.75%14.20M

245.24%18.43M

556.29%17.83M

148.23%8.54M

-135.22%-8.89M

8.39%-12.69M

-126.10%-3.91M

-44.29%-17.70M

465.73%25.24M

-106.18%-13.86M

174.93%14.97M

51.33%-12.27M

112.28%4.46M

833.67%224.09M

51.93%-19.98M

49.05%-25.21M

32.29%-36.33M

30.32%-30.54M

-10.93%-41.56M

-87.30%-49.48M

-68.75%-53.66M

-62.01%-43.84M

-0.75%-37.47M

59.86%-26.42M

25.32%-31.80M

-10.87%-27.06M

-83.58%-37.19M

-311.84%-65.82M

-30.21%-42.58M

-52.26%-24.41M

-80.85%-20.26M

-223.46%-15.98M

---32.70M

---16.03M

---11.20M

---4.94M

Operating gains losses

31.84%472.00K

35.65%468.00K

16.75%467.00K

-3.76%384.00K

-16.74%358.00K

-25.97%345.00K

-25.93%400.00K

-33.83%399.00K

-28.57%430.00K

-21.81%466.00K

-10.30%540.00K

22.31%603.00K

-7.53%602.00K

-9.15%596.00K

-9.88%602.00K

-25.08%493.00K

-9.21%651.00K

110.26%656.00K

17.81%668.00K

1.39%658.00K

20.50%717.00K

-47.47%312.00K

0.18%567.00K

24.09%649.00K

17.13%595.00K

26.11%594.00K

122.83%566.00K

4258.33%523.00K

4133.33%508.00K

5787.50%471.00K

3075.00%254.00K

50.00%12.00K

100.00%12.00K

33.33%8.00K

--8.00K

--6.00K

Deferred tax

0.64%2.66M

51.12%4.52M

199.21%3.14M

216.16%4.23M

-74.98%2.64M

-31.43%2.99M

87.70%-3.16M

-135.37%-3.64M

154.36%10.57M

305.29%4.37M

-7487.64%-25.71M

105.54%10.29M

---19.44M

--1.08M

3063.64%348.00K

---185.84M

----

-100.00%0.00

-72.50%11.00K

100.00%0.00

-100.18%-10.00K

100.96%10.00K

-84.31%40.00K

97.48%-51.00K

570.43%5.41M

-332.50%-1.04M

693.02%255.00K

-328.18%-2.02M

-256.04%-1.15M

-71.43%-240.00K

-48.28%-43.00K

-376.77%-472.00K

-822.86%-323.00K

-311.76%-140.00K

---29.00K

---99.00K

---35.00K

---34.00K

Other non-cash items

1280.00%1.10M

110.64%2.30M

-97.92%33.00K

479.40%1.55M

-87.65%80.00K

1.30%1.09M

259.64%1.59M

-87.57%267.00K

269.19%648.00K

589.09%1.08M

-24.62%441.00K

228.94%2.15M

-146.59%-383.00K

-124.47%-220.00K

-25.29%585.00K

-8.80%653.00K

3.66%822.00K

-10.37%899.00K

-21.78%783.00K

208.62%716.00K

263.76%793.00K

1293.06%1.00M

32.76%1.00M

123.46%232.00K

-63.11%218.00K

-98.83%72.00K

197.16%754.00K

-59.52%-989.00K

232.02%591.00K

20413.33%6.15M

---776.00K

---620.00K

17900.00%178.00K

2900.00%30.00K

----

--0.00

---1.00K

--1.00K

Change in working capital

452.22%5.87M

545.28%10.32M

25.99%25.88M

-118.15%-1.02M

83.19%-1.67M

-81.36%1.60M

618.48%20.54M

-49.12%5.60M

-66.19%-9.91M

3199.23%8.58M

83.46%-3.96M

-33.76%11.01M

-250.05%-5.96M

101.35%260.00K

-345.61%-23.95M

400.23%16.63M

189.57%3.97M

-2209.99%-19.22M

111.98%9.75M

-277.10%-5.54M

-56.84%-4.44M

109.89%911.00K

322.50%4.60M

189.27%3.13M

64.18%-2.83M

-37.26%-9.21M

-91.57%1.09M

-200.11%-3.50M

-657.77%-7.90M

-1475.61%-6.71M

43.67%12.93M

-27.93%3.50M

57.33%1.42M

159.15%488.00K

--9.00M

--4.86M

--900.00K

---825.00K

-Change in receivables

-103.26%-266.00K

-559.92%-7.63M

314.71%36.15M

-346.97%-19.83M

283.01%8.15M

-68.53%1.66M

7.62%-16.84M

-120.53%-4.44M

74.13%-4.46M

-59.11%5.27M

-99.03%-18.23M

744.85%21.61M

-179.63%-17.23M

150.65%12.89M

-1234.84%-9.16M

-397.92%-3.35M

947.98%21.63M

---25.45M

---686.00K

---673.00K

---2.55M

----

-Change in inventory

108.47%2.21M

-524.82%-18.25M

-682.86%-13.50M

9.83%6.79M

-244.49%-26.11M

11.73%4.29M

141.81%2.32M

480.18%6.18M

-1322.14%-7.58M

310.51%3.84M

20.62%-5.54M

-130.69%-1.63M

92.04%-533.00K

80.88%-1.83M

-461.37%-6.98M

583.23%5.29M

-4.89%-6.69M

---9.55M

--1.93M

--775.00K

---6.38M

----

-Change in prepaid expenses

-170.41%-18.57M

344.96%13.05M

-189.25%-12.32M

129.03%2.03M

48.23%-6.87M

-242.05%-5.33M

56.01%13.80M

50.01%-6.99M

-1971.23%-13.27M

242.37%3.75M

81.70%8.85M

-971.80%-13.99M

120.32%709.00K

33.01%-2.63M

155.27%4.87M

-206.10%-1.30M

-477.65%-3.49M

-1063.73%-3.93M

-56.99%1.91M

163.90%1.23M

81.39%-604.00K

168.23%408.00K

880.97%4.43M

-315.77%-1.93M

-1714.43%-3.25M

50.58%-598.00K

159.16%452.00K

56.40%-463.00K

106.34%201.00K

-693.14%-1.21M

-445.70%-764.00K

-128.88%-1.06M

-286.46%-3.17M

267.21%204.00K

--221.00K

---464.00K

---820.00K

---122.00K

-Change in other current assets

455.71%249.00K

-93.89%125.00K

-20.52%-3.04M

-1330.00%-143.00K

98.18%-70.00K

160.83%2.04M

-279.52%-2.52M

---10.00K

-4165.56%-3.84M

-202.88%-3.36M

630.57%1.41M

-100.00%0.00

-155.21%-90.00K

18.62%3.27M

88.09%-265.00K

100.13%1.00K

439.58%163.00K

1292.64%2.75M

60.18%-2.23M

---780.00K

---48.00K

---231.00K

---5.59M

----

-Change in other current liabilities

108.73%8.61M

105.07%6.79M

-79.88%4.00M

14937.14%5.26M

3538.33%4.13M

1369.35%3.31M

978.03%19.86M

101.58%35.00K

93.84%-120.00K

-103.89%-261.00K

84.15%-2.26M

-113.97%-2.21M

-17600.00%-1.95M

-44.15%6.70M

-2220.49%-14.27M

6267.32%15.85M

-103.30%-11.00K

299925.00%12.00M

-304.61%-615.00K

-141.25%-257.00K

793.75%333.00K

-92.73%4.00K

75.36%-152.00K

--623.00K

-111.06%-48.00K

-89.19%55.00K

---617.00K

--0.00

--434.00K

--509.00K

----

Cash from non-recurring investing activities

Cash from operating activities

68.01%47.20M

124.87%50.20M

187.13%53.89M

1606.13%33.68M

443.54%28.09M

459.92%22.32M

333.99%18.77M

-113.16%-2.24M

238.07%5.17M

193.44%3.99M

137.36%4.33M

-72.63%16.99M

52.16%-3.74M

88.42%-4.27M

38.70%-11.58M

317.66%62.05M

79.83%-7.82M

8.17%-36.85M

54.16%-18.88M

16.93%-28.51M

-32.71%-38.78M

-26.19%-40.12M

-70.42%-41.19M

-17.27%-34.32M

29.88%-29.22M

49.73%-31.80M

12.55%-24.17M

-42.87%-29.27M

-132.61%-41.68M

-322.50%-63.26M

-18.22%-27.64M

-87.20%-20.48M

-75.35%-17.92M

-163.64%-14.97M

---23.38M

---10.94M

---10.22M

---5.68M

Investing cash flow

Net cash from continuing investing activities

301.82%663.00K

62.63%161.00K

227.98%633.00K

--671.00K

760.00%165.00K

17.86%99.00K

244.64%193.00K

-100.00%0.00

-173.53%-25.00K

250.00%84.00K

233.33%56.00K

-50.00%16.00K

41.67%34.00K

--24.00K

-116.73%-42.00K

-37.25%32.00K

-59.32%24.00K

-100.00%0.00

356.36%251.00K

920.00%51.00K

--59.00K

8892.83%20.05M

-97.24%55.00K

-98.86%5.00K

100.00%0.00

-85.71%223.00K

-50.30%2.00M

-54.31%440.00K

-436.44%-794.00K

1981.33%1.56M

100300.00%4.02M

3339.29%963.00K

1142.11%236.00K

316.67%75.00K

--4.00K

--28.00K

--19.00K

--18.00K

Capital expenditures

301.82%663.00K

62.63%161.00K

227.98%633.00K

--671.00K

--165.00K

17.86%99.00K

244.64%193.00K

-100.00%0.00

250.00%84.00K

--56.00K

-50.00%16.00K

-70.43%34.00K

--24.00K

----

-37.25%32.00K

94.92%115.00K

-100.00%0.00

356.36%251.00K

920.00%51.00K

--59.00K

8892.83%20.05M

-97.24%55.00K

-98.86%5.00K

--0.00

-85.71%223.00K

-50.30%2.00M

-54.31%440.00K

----

1981.33%1.56M

100300.00%4.02M

3339.29%963.00K

1142.11%236.00K

316.67%75.00K

--4.00K

--28.00K

--19.00K

--18.00K

Net cash flow from disposal of fixed assets

301.82%663.00K

62.63%161.00K

227.98%633.00K

--671.00K

760.00%165.00K

17.86%99.00K

244.64%193.00K

-100.00%0.00

-173.53%-25.00K

250.00%84.00K

233.33%56.00K

-50.00%16.00K

41.67%34.00K

--24.00K

-116.73%-42.00K

-37.25%32.00K

-59.32%24.00K

-100.00%0.00

356.36%251.00K

920.00%51.00K

--59.00K

-75.78%54.00K

-97.24%55.00K

-98.86%5.00K

--0.00

-85.71%223.00K

-50.30%2.00M

-54.31%440.00K

----

1981.33%1.56M

100300.00%4.02M

3339.29%963.00K

1142.11%236.00K

316.67%75.00K

--4.00K

--28.00K

--19.00K

--18.00K

Net cash flow from intangible asset transactions

----

--0.00

-100.00%0.00

--0.00

--20.00M

----

Net cash flow from investment products

-1861.19%-72.92M

38.27%-31.75M

-207.17%-70.18M

-878.01%-62.08M

92.06%-3.72M

-300.88%-51.44M

541.34%65.49M

48.23%-6.35M

-231.64%-46.82M

167.57%25.61M

65.25%-14.84M

-164.29%-12.26M

-7.11%35.57M

-66.77%-37.90M

14.24%-42.70M

-60.18%19.07M

-55.50%38.29M

-135.02%-22.72M

-172.48%-49.79M

132.01%47.90M

375.66%86.05M

-27.10%64.89M

1656.08%68.70M

-1056.08%-149.66M

-176.95%-31.22M

1253.47%89.01M

-88.38%3.91M

108.07%15.65M

155.06%40.57M

---7.72M

--33.68M

---193.91M

---73.68M

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-1794.93%-73.58M

38.08%-31.92M

-208.46%-70.81M

-888.58%-62.76M

91.70%-3.88M

-301.93%-51.54M

538.38%65.29M

48.29%-6.35M

-231.70%-46.80M

167.31%25.52M

65.09%-14.89M

-164.48%-12.28M

-7.14%35.53M

-66.88%-37.92M

14.75%-42.66M

-60.21%19.04M

-55.50%38.27M

-150.68%-22.72M

-172.90%-50.04M

131.97%47.85M

375.47%85.99M

-49.51%44.83M

3482.62%68.64M

-1083.76%-149.66M

-175.47%-31.22M

1057.00%88.79M

-93.54%1.92M

107.81%15.21M

155.96%41.36M

-12270.67%-9.28M

741600.00%29.66M

-695867.86%-194.87M

-388910.53%-73.91M

-316.67%-75.00K

---4.00K

---28.00K

---19.00K

---18.00K

Financing cash flow

Cash flow from continuous financing activities

13.20%12.11M

119.40%6.07M

257.52%7.66M

77.89%11.90M

6110.11%10.70M

-23.39%2.77M

208.20%2.14M

1111.78%6.69M

-212.66%-178.00K

3914.44%3.61M

-41.60%695.00K

52.91%552.00K

-70.85%158.00K

-78.72%90.00K

-1.82%1.19M

-86.53%361.00K

-38.90%542.00K

-61.75%423.00K

70.22%1.21M

-98.17%2.68M

-98.86%887.00K

-54.18%1.11M

90.88%712.00K

276124.53%146.40M

15600.61%77.56M

-97.10%2.41M

28.18%373.00K

106.96%53.00K

-99.68%494.00K

-56.40%83.19M

--291.00K

---762.00K

--156.40M

378.54%190.81M

--0.00

--39.87M

Net cash flow from common stock issuance/repurchase

37.92%17.58M

100.91%6.39M

215.29%8.58M

72.88%16.25M

1022.91%12.74M

-20.38%3.18M

184.22%2.72M

467.35%9.40M

96.71%1.14M

683.14%3.99M

-25.81%957.00K

191.21%1.66M

1.94%577.00K

-48.59%510.00K

6.44%1.29M

-78.77%569.00K

-36.19%566.00K

-10.31%992.00K

38.99%1.21M

-98.17%2.68M

-98.86%887.00K

-54.18%1.11M

133.78%872.00K

276892.45%146.81M

15159.77%78.13M

-97.10%2.41M

-1.32%373.00K

--53.00K

-99.68%512.00K

--83.29M

--378.00K

--0.00

--159.19M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

----

--0.00

----

--0.00

378.57%190.82M

--0.00

--39.87M

Proceeds from stock option exercised by employees

----

--59.00K

--0.00

--17.00K

--0.00

Net cash flow from other financing activities

-167.12%-5.47M

23.30%-316.00K

-58.82%-918.00K

-60.51%-4.35M

-55.90%-2.05M

-8.14%-412.00K

-120.61%-578.00K

-145.43%-2.71M

-213.37%-1.31M

9.29%-381.00K

-162.00%-262.00K

-431.25%-1.10M

-1645.83%-419.00K

26.19%-420.00K

---100.00K

---208.00K

---24.00K

---569.00K

----

100.00%0.00

----

---160.00K

---407.00K

-3061.11%-569.00K

100.00%0.00

99.36%-18.00K

-244.83%-100.00K

---87.00K

---821.00K

---2.80M

---29.00K

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

13.20%12.11M

119.40%6.07M

257.52%7.66M

77.89%11.90M

6110.11%10.70M

-23.39%2.77M

208.20%2.14M

1111.78%6.69M

-212.66%-178.00K

3914.44%3.61M

-41.60%695.00K

52.91%552.00K

-70.85%158.00K

-78.72%90.00K

-1.82%1.19M

-86.53%361.00K

-38.90%542.00K

-61.75%423.00K

70.22%1.21M

-98.17%2.68M

-98.86%887.00K

-54.18%1.11M

90.88%712.00K

276124.53%146.40M

15600.61%77.56M

-97.10%2.41M

28.18%373.00K

106.96%53.00K

-99.68%494.00K

-56.40%83.19M

--291.00K

---762.00K

--156.40M

378.54%190.81M

--0.00

--39.87M

Net cash flow

Beginning cash balance

----

-9.80%165.60M

79.57%174.86M

93.45%192.04M

11.38%157.13M

70.05%183.58M

-17.36%97.38M

-11.81%99.27M

75.00%141.08M

-12.03%107.95M

-32.96%117.83M

19.36%112.57M

27.31%80.62M

0.20%122.72M

-7.58%175.76M

-43.92%94.31M

-47.26%63.32M

7.20%122.47M

120.93%190.18M

35.98%168.16M

12.69%120.07M

142.37%114.25M

24.73%86.08M

48.96%123.67M

28.62%106.55M

-34.70%47.14M

-1.22%69.02M

-70.97%83.02M

-62.59%82.84M

58.09%72.19M

1.20%69.87M

257.43%285.99M

145.34%221.42M

-18.57%45.66M

--69.04M

--80.01M

--90.25M

--56.08M

Current period cash flow changes

-140.90%-14.28M

192.09%24.36M

-110.74%-9.26M

-806.54%-17.18M

183.49%34.91M

-179.85%-26.45M

973.05%86.20M

-136.02%-1.90M

-230.86%-41.81M

178.68%33.12M

81.39%-9.87M

-93.54%5.26M

3.12%31.95M

28.83%-42.10M

21.66%-53.05M

269.91%81.45M

-35.58%30.98M

-1116.60%-59.15M

-340.42%-67.71M

158.59%22.02M

180.94%48.10M

-90.21%5.82M

228.71%28.16M

-168.42%-37.58M

9358.56%17.12M

457.66%59.41M

-1046.00%-21.88M

93.52%-14.00M

-99.72%181.00K

-93.94%10.65M

109.89%2.31M

-1869.90%-216.12M

730.73%64.57M

414.29%175.76M

---23.38M

---10.97M

---10.24M

--34.18M

Ending cash balance

-8.52%175.68M

20.89%189.95M

-9.80%165.60M

79.57%174.86M

93.45%192.04M

11.38%157.13M

70.05%183.58M

-17.36%97.38M

-11.81%99.27M

75.00%141.08M

-12.03%107.95M

-32.96%117.83M

19.36%112.57M

27.31%80.62M

0.20%122.72M

-7.58%175.76M

-43.92%94.31M

-47.26%63.32M

7.20%122.47M

120.93%190.18M

35.98%168.16M

12.69%120.07M

142.37%114.25M

24.73%86.08M

48.96%123.67M

28.62%106.55M

-34.70%47.14M

-1.22%69.02M

-70.97%83.02M

-62.59%82.84M

58.09%72.19M

1.20%69.87M

257.43%285.99M

145.34%221.42M

--45.66M

--69.04M

--80.01M

--90.25M

Free cash flow

66.63%46.53M

125.14%50.04M

186.70%53.26M

1576.12%33.01M

440.34%27.93M

469.43%22.23M

335.16%18.58M

-113.18%-2.24M

236.83%5.17M

190.96%3.90M

--4.27M

-72.64%16.97M

52.42%-3.78M

88.35%-4.29M

----

317.16%62.02M

79.56%-7.94M

38.77%-36.85M

53.61%-19.14M

16.80%-28.56M

-32.91%-38.84M

-87.94%-60.18M

-57.63%-41.25M

-15.55%-34.33M

---29.22M

50.60%-32.02M

17.34%-26.17M

-38.51%-29.71M

----

-330.76%-64.82M

-35.37%-31.65M

-95.50%-21.45M

-77.33%-18.15M

-164.12%-15.05M

---23.38M

---10.97M

---10.24M

---5.70M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Kiniksa Pharmaceuticals International PLC Generate?



Kiniksa Pharmaceuticals International PLC generated 137.99M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Kiniksa Pharmaceuticals International PLC's Operating Cash Flow Change Year Over Year?



Kiniksa Pharmaceuticals International PLC's operating cash flow increased by 437.14% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Kiniksa Pharmaceuticals International PLC Spend on Capital Expenditures?



Kiniksa Pharmaceuticals International PLC spent 1.57M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Kiniksa Pharmaceuticals International PLC's Financing Cash Flow Changed?



Kiniksa Pharmaceuticals International PLC used 33.02M in financing activities in the latest quarter.

What is free cash flow and why does it matter for KNSA?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Kiniksa Pharmaceuticals International PLC’s free cash flow in the latest quarter?



Free cash flow was 136.42M reflecting a 436.82% change from the previous year.